NASDAQ · Medical - Diagnostics & Research

IDXX (IDXX) Stock

$545.71 -1.97% NASDAQ: IDXX Healthcare

Valuation

MetricValue
Price$545.71
Market Cap$43.05B
P/E Ratio38.87
P/B Ratio27.49
P/S Ratio9.59
EPS (TTM)$13.08
52-Week High$769.98
52-Week Low$518.55
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE71.96%
ROA33.11%
ROCE67.69%
Gross Margin31.60%
Operating Margin31.60%
Net Margin25.03%
Debt/Equity0.68
Current Ratio1.17

Annual Financials (USD)

Metric20212022202320242025
Revenue$3.2B$3.4B$3.7B$3.9B$4.3B
Operating Profit$932.0M$899.0M$1.1B$1.1B$1.4B
Net Profit$745.0M$679.0M$845.0M$888.0M$1.1B
EPS$8.60$8.03$10.06$10.67$13.08
Op Margin29.0%26.7%30.0%28.9%31.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.4B$2.7B$3.3B$3.3B$3.4B
Total Liabilities$1.7B$2.1B$1.8B$1.7B$1.7B
Cash$144.0M$113.0M$454.0M$288.0M$180.0M
Borrowings$1.0B$1.5B$1.1B$987.0M$1.1B

Latest News

IDXX: Lowering target price to $595.00 Argus Research · Jul 15, 2026 These 3 Water ETFs Could be Quiet Winners From Infrastructure Spending MarketBeat · Jul 14, 2026 Buy 3 AI-Led Medical Devices Laggards of 1H Set to Gather Pace in 2H Zacks · Jul 14, 2026 IDEXX Laboratories Earnings Preview: What to Expect Barchart · Jul 13, 2026 Leerink Partners Adjusts IDEXX Laboratories Price Target to $715 From $725, Maintains Outperform Rating MT Newswires · Jul 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$756.0M$543.0M$907.0M$929.0M$1.2B
Investing Cash Flow$-413.0M$-344.0M$-259.0M$-338.0M$-261.0M
Financing Cash Flow$-767.0M$-837.0M$-85.0M$-848.0M$-1.2B
Net Cash Flow$-239.0M$-32.0M$341.0M$-166.0M$-108.0M
Free Cash Flow$636.0M$394.0M$773.0M$798.0M$1.1B

Valuation & Return Ratios

MetricValue
PEG Ratio2.20
EV / EBITDA27.54
FCF Yield2.86%
Quick Ratio0.87
Interest Coverage37.31
Return 1Y-14.23%
Return 3Y8.50%
Return 5Y-17.18%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
A $149.87 -2.40% 30.48 $42.33B 0.66%
ALNY $239.96 -0.30% 73.95 $32.11B 0.00%
ARGXargenx SE $862.93 +0.41% 48.25 $53.99B 0.00%
BDX $187.70 -0.22% 57.29 $51.72B 2.21%
CAH $239.04 +1.88% 32.79 $55.98B 0.86%

About IDXX

IDXX is led by CEO Jonathan J. Mazelsky, employs 11,000 people, headquartered in Westbrook, US, publicly traded since 1991.

IDXX stock trades at $545.71 with a market capitalization of $43.05B. The stock is valued at a price-to-earnings (P/E) ratio of 38.87, price-to-book of 27.49, price-to-sales of 9.59. Over the past 52 weeks the stock has ranged between $518.55 and $769.98, and currently trades 29.1% below its 52-week high.

On profitability, IDXX generates a return on equity (ROE) of 71.96% — well above the market average, a sign of a high-quality business, return on capital employed of 67.69%, an operating margin of 31.60%, a net profit margin of 25.03%.

In its most recent fiscal year, IDXX reported annual revenue of $4.3B, net profit of $1.1B, revenue has compounded at 9.7% a year over the last five years, profit at 12.7% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.68, a current ratio of 1.17, total assets of $3.4B, $180.0M in cash and equivalents.

IDXX has a beta of 1.54 (more volatile than the overall market).

Related Healthcare Stocks

LLY Drug Manufacturers - General $1164.19 +0.64% JNJ Drug Manufacturers - General $270.06 +1.58% ABBV Drug Manufacturers - General $261.00 +1.79% MRK Drug Manufacturers - General $149.18 +0.96% UNH Medical - Healthcare Plans $395.60 +1.59% NVS Drug Manufacturers - General $161.66 +6.31% AZN Drug Manufacturers - General $161.97 -0.10% AMGN Drug Manufacturers - General $437.27 +1.72% TMO Medical - Diagnostics & Research $602.27 -2.40% NVO Biotechnology $45.29 -0.09% ABT Medical - Devices $109.56 -0.72% GILD Drug Manufacturers - General $149.07 +1.86%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides